226950.KQ
OliX Pharmaceuticals,Inc
KOE · Healthcare · Biotechnology · KR
KRW 91,800.00
−8.38%Leverage
- Debt / equity
- 0.09x
- Net debt / equity
- -0.38x
- Debt / assets
- 0.08x
- Debt / EBITDA
- -0.53x
- Net debt / EBITDA
- 2.31x
Liquidity & coverage
- Current ratio
- 11.74x
- Quick ratio
- 11.71x
- Cash ratio
- 11.45x
- Interest coverage
- -37.37x
- EBITDA / interest
- -35.27x
- Working capital
- KRW 200.9B
Cash & dividend
- FCF / debt
- -1.54x
- Cash flow / debt
- -1.44x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026